Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
71,086,297
-
Share change
-
-363,541
-
Total reported value
-
$1,057,032,461
-
Put/Call ratio
-
2.5%
-
Price per share
-
$14.87
-
Number of holders
-
299
-
Value change
-
-$156,051
-
Number of buys
-
161
-
Number of sells
-
124
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2025
As of 31 Mar 2025,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
299 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,086,297 shares.
The largest 10 holders included
Capital Research Global Investors, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, FMR LLC, BRANDES INVESTMENT PARTNERS, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, FIRST TRUST ADVISORS LP, BlackRock, Inc., and VAN ECK ASSOCIATES CORP.
This page lists
302
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.